Top global companies by orphan drug revenues 2017

The data shows the top pharmaceutical companies worldwide based on the revenues generated by orphan drug sales in 2017. During that year, Pfizer was among the world's top companies, totaling 4.9 billion USD in orphan drug revenue. Orphan drugs are developed to treat a specific rare medical condition, often called an orphan disease. In many countries, public policy determines the characteristics behind specifying orphan diseases and drugs.